VanderbiltHealth.com: For Patients and Visitors
Vanderbilt University Medical Center: For Employees, Researchers, and Students

Eric L. Grogan, MD, MPH

 

Principal Investigator

Assistant Professor, Department of Thoracic Surgery
Department of Medicine, Institute for Medicine and Public Health
Veterans Affairs Hospital
Download CV  |  Biography -
Section of Surgical Sciences  |  Dr. Grogan at VICC

 

Dr. Grogan's clinical practice includes all areas of general thoracic surgery. He joined Vanderbilt in 2008 as assistant professor in the department of Thoracic Surgery. He also serves as a staff thoracic surgeon at the Veterans Hospital in Nashville and is Assistant Professor of Medicine for the Institute for Medicine and Public Health. He has experience in the treatment of lung and esophageal cancer, lung failure surgery, lung transplantation, mediastinal tumors, and tracheal and bronchoplastic procedures. Dr. Grogan's clinical interests have focused on minimally invasive thoracic surgery for treatment of lung cancer and benign esophageal diseases. He performs VATS lobectomies, radiotracer guided excision of small pulmonary nodules, and laparoscopic and thoracoscopic esophageal surgical procedures.

As a Thoracic Surgeon, Dr. Grogan evaluates and treats patients with known or suspected lung cancer and clinical and pathologic staging are part of his daily clinical responsibilities. His past research interests focused on health services research in surgical patients: developing and implementing new monitoring strategies for critically ill patients, performing comparative effectiveness studies for new surgical technologies and designing tools to improve observed to expected mortality ratios in surgical patients. In 2006 he began a cardiothoracic residency to clinical and research efforts on improving the diagnosis and treatment of lung cancer.

Research efforts have allowed the team to identify populations of patients who are at higher risk for benign disease and begin developing models to predict benign and malignant disease in surgical populations. In an attempt to improve our diagnostic capabilities, he has evaluated the predictive capabilities of serum biomarkers in surgical patients and radiographic imaging. Recent SPORE pilot funding has also allowed his team to develop techniques that will allow surgeons to image, localize, and excise small suspicious nodules. So in order to improve our preoperative diagnostic accuracy and reduce non-therapeutic operations for benign disease, the TREAT Lung Cancer team is attempting to improve the predictive models, introduce molecular diagnostics, and improve imaging and localization technology. These models and new technologies will allow us to use genomics, proteomics, sophisticated modeling and diagnostic tools to personalize the diagnosis and treatment of early stage lung cancer. The team is investigating why certain tests such as FDG-PET scans, biomarkers and surgical biopsies perform differently for different populations.

Dr. Grogan is a member of the Institute for Medicine and Public Health, Vanderbilt Ingram Cancer Center and mentors clinical thoracic surgery fellows, post doctoral research fellows, graduate students and medical students.

 

 

Copyright © 2014 by Vanderbilt University Medical Center    |    1211 Medical Center Drive    |    Nashville, TN 37232    |    (615) 322-5000
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
This page was last updated July 31, 2013 and is maintained by Vicki Gann